Certified by Founder Lodge
Actio Biosciences, Inc.
United States - San Diego, California
START UP
1 Disclosed Funding Rounds $55,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We’re leveraging advances in genetics and precision medicine to develop new therapeutics that target shared, underlying biology in rare and common diseases — bringing meaningful medicines fro
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 15 ,2023 | Series A | $55,000,000 | |
| June, 19 ,2025 | Series B | $66,000,000.00 | |
| June, 19 ,2025 | Series B | $66,000,000.00 |
Droia Ventures
Deerfield Management
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
